Table 1.
The clinical characteristics of the patients
| Group 1 | Group 2 | p value | |
|---|---|---|---|
| Number of patients (n, %) | 32 (36.78) | 55 (63.21) | |
| Age (years) | 64 | 65 | 0.16 |
| BMI (kg/m2) | 27 | 28 | 0.83 |
| PSA (ng/ml) | 7 | 7 | 0.55 |
| Diabetes Mellitus (n, %) | 8 (25) | 16 (29) | 0.68 |
| Hypertension (n, %) | 7 (21.87) | 11 (20) | 0.83 |
| Gleason score | 7 | 7 | 0.29 |
| Tumor volume (cc) | 2 | 2.2 | 0.73 |
| Follow-up (months) | 36 | 48 | <0.05* |
| Local advanced disease (T3-4) (n, % for group) | 11 (34.75) | 16 (29.09) | 0.60 |
| Positive surgical margin (n, %) | 12 (37.50) | 16 (29.09) | 0.42 |
| HGPCa (n, %) | 21 (65.62) | 28 (50.90) | 0.18 |
| BCR (n, %) | 5 (15.62) | 10 (18.18) | 0.76 |
HGPCa – high grade prostate cancer; BCR – biochemical recurrence; BMI – body mass index
Mann Whitney U test for median values and chi-squared test for percentage were performed
*
statistically significant